Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Management of Peripheral Arterial Disease after Menopause

Author(s): Theofanis Papas*

Volume 22, Issue 4, 2024

Published on: 26 December, 2023

Page: [234 - 235] Pages: 2

DOI: 10.2174/0115701611288783231212062901

Price: $65

« Previous Next »
[1]
Anagnostis P, Mikhailidis DP, Blinc A, et al. The effect of menopause and menopausal hormone therapy on the risk of peripheral artery disease. Curr Vasc Pharmacol 2023; 21(5): 293-6.
[http://dx.doi.org/10.2174/0115701611263345230919122907] [PMID: 37779405]
[2]
Poredoš P, Schernthaner GH, Blinc A, et al. Endocrine disorders and peripheral arterial disease: A series of reviews. Curr Vasc Pharmacol 2023; 21(3): 147-8.
[http://dx.doi.org/10.2174/1570161121666230516141319] [PMID: 37194233]
[3]
Janez A, Herman R, Poredos P, et al. Cardiometabolic risk, peripheral arterial disease and cardiovascular events in polycystic ovary syndrome: Time to implement systematic screening and update the management. Curr Vasc Pharmacol 2023; 21.
[http://dx.doi.org/10.2174/0115701611269146230920073301] [PMID: 37779406]
[4]
Blinc A, Schernthaner GH, Poredoš P, et al. Testosterone and peripheral arterial disease. Curr Vasc Pharmacol 2023; 21(5): 297-303.
[http://dx.doi.org/10.2174/1570161121666230809143023] [PMID: 37559242]
[5]
Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43(7): 1334-59.
[http://dx.doi.org/10.1249/MSS.0b013e318213fefb] [PMID: 21694556]
[6]
Chomistek AK, Manson JE, Stefanick ML, et al. Relationship of sedentary behavior and physical activity to incident cardiovascular disease: Results from the Women’s Health Initiative. J Am Coll Cardiol 2013; 61(23): 2346-54.
[http://dx.doi.org/10.1016/j.jacc.2013.03.031] [PMID: 23583242]
[7]
Mauer K, Exaire JE, Stoner JA, Guthery LD, Montgomery PS, Gardner AW. Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease. Angiology 2010; 61(7): 698-704.
[http://dx.doi.org/10.1177/0003319710369100] [PMID: 20529977]
[8]
Brevetti G, Bucur R, Balbarini A, et al. Women and peripheral arterial disease: Same disease, different issues. J Cardiovasc Med 2008; 9(4): 382-8.
[http://dx.doi.org/10.2459/JCM.0b013e3282f03b90] [PMID: 18334893]
[9]
Katsiki N, Giannoukas AD, Athyros VG, Mikhailidis DP. Lipid-lowering treatment in peripheral artery disease. Curr Opin Pharmacol 2018; 39(2): 19-26.
[http://dx.doi.org/10.1016/j.coph.2018.01.003] [PMID: 29413998]
[10]
Belur AD, Shah AJ, Virani SS, Vorla M, Kalra DK. Role of lipid-lowering therapy in peripheral artery disease. J Clin Med 2022; 11(16): 4872.
[http://dx.doi.org/10.3390/jcm11164872] [PMID: 36013107]
[11]
Sagris M, Katsaros I, Giannopoulos S, et al. Statins and statin intensity in peripheral artery disease. Vasa 2022; 51(4): 198-211.
[http://dx.doi.org/10.1024/0301-1526/a001012] [PMID: 35673949]
[12]
Sofat S, Chen X, Chowdhury MM, Coughlin PA. Effects of statin therapy and dose on cardiovascular and limb outcomes in peripheral arterial disease: A systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2021; 62(3): 450-61.
[http://dx.doi.org/10.1016/j.ejvs.2021.05.025] [PMID: 34389230]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy